The latter report showed an inverse relationship of a single obesity-related SNP (FTO rs9939609) with overall- and low-grade prostate cancer in ProtecT, a much smaller population-based sample of 1,550 screen-detected prostate cancers and 1,815 controls [15]. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.